GHK-Cu

Mechanism: GHK-Cu upregulates structural proteins like decorin and biglycan, downregulates scar-forming pathways, and balances metalloproteinase activity.

Sequence: Gly-His-Lys [Cu2+ Complexed Variant]

Recommended Dosage: Subcutaneous injection standard is 1mg to 2mg daily. Topical formulations typically demand 1% to 3% serum concentrations.

Tracking Cycle: Continuous application metrics map structural adjustments over 30 to 60-day testing blocks.